Recursion Pharmaceuticals
clinical disease overview difficile infection | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
120 of 143
Related slides by other companies
BioAtla
Investor Presentation
May 2023
is a clinical stage company focused on transforming cancer therapy | BioAtla
Aeglea BioTherapeutics
Investor Presentation
May 2023
program overview | Aeglea BioTherapeutics
Minerva
IPO
October 2021
clinical trials overview | Minerva
BioAtla
Investor Presentation
August 2023
summary of dosing regimens for phase clinical studies with cab | BioAtla
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io